Medical Gas and Equipment Market Size, Share, Growth, and Industry Analysis, By Type (Oxygen,Nitrous Oxide,Carbon Dioxide,Gas Mixture,Vacuum System,Others), By Application (Hospital,Home Healthcare), Regional Insights and Forecast to 2035

Medical Gas and Equipment Market Overview

The global Medical Gas and Equipment Market size is projected to grow from USD 14114.53 million in 2026 to USD 14608.54 million in 2027, reaching USD 19236.66 million by 2035, expanding at a CAGR of 3.5% during the forecast period.

The global Medical Gas and Equipment Market is characterised by increasing installed base of delivery systems and gases. In 2024 the global market size was reported at approximately USD 18.1 billion, exhibiting strong utilization across hospital, home-care and other care settings. In 2023, the medical gases component captured around 37.8 % share of the total market by product, while the packaged cylinder modality accounted for about 45.8 % of the product mix. Hospitals accounted for 62.6 % of end-use in 2024, demonstrating the dominance of institutional demand. The region of North America held around 35.9 % of the market value in 2024, indicating regional leadership.

In the United States, the medical gas and equipment market reflects mature infrastructure and high adoption. The U.S. portion of the North American market accounted for approximately 85.1 % of that region’s share in 2024, with home healthcare and hospital segments expanding. In U.S. medical gases only, the market size stood at about USD 3.9 billion in 2024, with hospitals comprising roughly 55 % of the end-use share and therapeutics applications accounting for about 45 % of application share. Regionally within the U.S., the Southern region held approximately 40 % of the U.S. market share in 2024, the West region about 28 %, Midwest about 24 % and Northeast roughly 22 %.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver:8 % of the global market share derives from pure medical gases as of 2024.
• Major Market Restraint:2 % of North America market value is tied to the medical gas equipment product segment, implying large capital intensity.
• Emerging Trends:1 % of North America volume in 2024 was for therapeutic applications, indicating growing end‐use diversification.
• Regional Leadership: North America held approximately 40 % of the global market value in 2024.
• Competitive Landscape: Top product types indicate that oxygen and medical air dominate; e.g., one report shows oxygen segment at ~42.2 % share of medical gases in 2025.
• Market Segmentation: Hospitals as end-use accounted for 62.6 % of value in 2024 globally.
• Recent Development: The Asia-Pacific region begins 2023 market value at USD 2.88 billion (for medical gas and equipment) out of global total, indicating the region’s emerging scale.

Medical Gas and Equipment Market Latest Trends

The Medical Gas and Equipment Market is experiencing accelerated shift towards home-based care and portable systems, with portable concentrators seeing rapidly increasing adoption. In 2024 the therapeutic application segment accounted for more than 52 % of global value, as patients with chronic respiratory diseases, such as COPD and asthma (affecting over 260 million people globally), receive oxygen therapy outside hospital settings. The pure medical gases product segment held approximately 37.8 % of the market in 2024, showing the foundational role of gas supply systems. Packaged cylinders accounted for nearly 45.8 % of modality share in 2024, indicating the enduring relevance of traditional delivery formats. In equipment, the hospital end-use segment held about 62.6 % of value in 2024, suggesting majority of demand remains institution-based. Regionally, North America led with approximately 35.9 % share in 2024, while Asia-Pacific emerged with fastest growth trajectory, underpinned by increasing healthcare facility builds and large population base. Among the gases, oxygen remains the principal component, estimated at 42.2 % share of medical gases in 2025, followed by nitrous oxide and carbon dioxide. Equipment vendors are increasingly integrating digital monitoring and remote verification systems, enabling real-time pipeline and manifold management, while home systems are trending towards lightweight cylinders and on-site generation units. The medical gas mixtures segment is gaining traction, driven by procedural use (e.g., anesthesia, diagnostics) especially in specialist centres. Overall, the Market is moving from basic infrastructure installations to advanced, connected solutions across hospital and home environments, offering strong opportunities for B2B players in supply, servicing and lifecycle management.

Medical Gas and Equipment Market Dynamics

DRIVER

"Rising prevalence of chronic respiratory and cardiovascular diseases"

As the global incidence of chronic conditions such as COPD, asthma and heart failure increases, demand for medical gas therapy and associated equipment rises. For example, asthma affects over 260 million people worldwide and leads to substantial use of oxygen and inhalation-based therapies. Additionally, hospitals are upgrading ICU and surgical care units, driving equipment installations — in 2024 the hospitals segment accounted for about 62.6 % of the global market value. The growth in home oxygen therapy—more than 1.5 million Americans receive home oxygen support annually—further expands the addressable market. Equipment such as vacuum systems/pumps, manifold systems and gas generation units are seeing increased demand; one report shows vacuum systems/pumps dominate among product types in 2023. This dynamic presents B2B market opportunities in supply of pure gases, equipment integration, installation and service contracts.

RESTRAINT

"High upfront capital and regulatory compliance burdens"

The Medical Gas and Equipment Market is constrained by the high capital required for infrastructural deployment of pipeline systems, manifold installations and safety‐critical equipment. In North America, the equipment product segment represented about 56.2 % of total value in 2024, illustrating the heavy investment component. Regulatory and safety standards such as NFPA 99 and local health authority mandates impose rigorous compliance, slowing project roll‐out especially in smaller facilities. Moreover, maintenance and servicing overheads over long service lifecycles add to total cost of ownership, which can deter smaller clinics or ambulatory centres. The high cost structure may limit uptake in price-sensitive regions and restrain volume expansion in emerging markets.

OPPORTUNITY

"Expansion into emerging markets and home healthcare systems"

Emerging regions such as Asia-Pacific, Latin America and Middle East & Africa are investing in healthcare infrastructure; for instance the Asia-Pacific medical gas and equipment market value stood at USD 2.88 billion in 2023. Home healthcare is becoming a major focus: therapeutic application share globally reached more than 52 % in 2024, indicating growing out-of-hospital usage. Suppliers can capitalise on growth in portable concentrators, modular on-site generation units and home delivery/maintenance services. Given the hospital segment is already saturated in many developed markets (holding 62.6 % of value), growth pivots to home care, clinics and outpatient surgical centres. B2B stakeholders—including gas suppliers, equipment manufacturers, service providers—can target partnerships, retrofit programmes, remote‐monitoring add-ons and expansion into under-penetrated geographies to capture new volume.

CHALLENGE

"Supply chain volatility and scarce specialty gas availability"

The Medical Gas and Equipment Market faces challenges in securing stable supply of specialty gases (such as helium, high-purity nitrogen, medical air) and in managing logistics of cylinders, on-site generation and refill systems. Disruptions (for example due to global helium supply scarcity) introduce cost pressures and delivery delays. In equipment, integrating legacy gas pipeline systems with new digital monitoring also requires skilled technicians and service infrastructure—a constraint in many markets. Move to remote monitoring and connected systems increases demands on cybersecurity, data privacy and interoperability standards, posing additional challenge layers. Stakeholders must align with supply chain resilience strategies and invest in service networks to mitigate these risks.

Medical Gas and Equipment Market Segmentation

The Medical Gas and Equipment Market is segmented by Type and Application for B2B buyers. By Type, segments include Hospital and Home Healthcare. By Application, segments include Oxygen, Nitrous Oxide, Carbon Dioxide, Gas Mixture, Vacuum System and Others.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Hospital: The hospital type segment accounts for the vast majority of demand, capturing approximately 62.6 % of market value in 2024. Hospitals require centralised pipeline systems, manifold assemblies, high-pressure cylinders and monitoring systems across operating theatres, ICUs, emergency rooms and neonatal units. For example, packaged cylinder modality held about 45.8 % of product modality share in 2024, reflecting heavy cylinder use in institutional settings. Hospitals also consume pure medical gases segment, which held 37.8 % of global product value by 2024. For B2B suppliers, hospitals represent high value contracts, ongoing maintenance service opportunities and long-term supply agreements.

The Hospital segment is projected to reach a market size of USD 9,460.21 million by 2034, holding approximately 51.3% share of the total market and expanding at a CAGR of 3.4% due to increasing surgical and emergency care needs.

Top 5 Major Dominant Countries in the Hospital Segment

• United States: Expected to reach USD 2,940.10 million by 2034, accounting for 31.1% share and growing at a CAGR of 3.3%, driven by widespread hospital networks and intensive care requirements.
• Germany: Estimated at USD 1,010.42 million by 2034, with a 10.6% market share and a CAGR of 3.2%, supported by strong hospital infrastructure and advanced medical gas usage.
• Japan: Set to reach USD 905.75 million by 2034, securing a 9.6% market share and a CAGR of 3.5%, propelled by aging population and increasing hospital admissions.
• China: Projected at USD 890.60 million by 2034, representing 9.4% share and a CAGR of 3.7%, driven by healthcare expansion and rising public hospital investments.
• United Kingdom: Expected to reach USD 765.20 million by 2034, accounting for 8.1% share with a CAGR of 3.3%, backed by rising hospital-based therapeutic procedures.

Home Healthcare: The home healthcare type segment is gaining momentum, supported by the therapeutic application share (~52 % in 2024) and growing portable system usage. Home oxygen concentrators, lightweight cylinders, modular delivery units and monitoring systems are increasingly adopted. While institutional value dominance continues, the home healthcare segment offers faster growth potential and lower entry intervention. This segmentation opens opportunities for gas suppliers, equipment OEMs and service providers targeting rental, subscription models and remote service networks.

The Home Healthcare segment is anticipated to reach USD 9,020.01 million by 2034, holding a 48.7% market share and growing at a CAGR of 3.6%, driven by increasing patient preference for home-based oxygen and respiratory therapy.

Top 5 Major Dominant Countries in the Home Healthcare Segment

• United States: Forecasted to reach USD 2,630.55 million by 2034, capturing 29.2% share with a CAGR of 3.7%, supported by strong adoption of home oxygen therapy systems.
• China: Estimated at USD 1,125.64 million by 2034, with 12.5% market share and CAGR of 3.9%, driven by the rising aging population and chronic respiratory illnesses.
• India: Projected to achieve USD 890.12 million by 2034, capturing 9.9% share and a CAGR of 4.1%, due to expanding home healthcare infrastructure and government support.
• Germany: Expected at USD 845.76 million by 2034, holding 9.3% share and a CAGR of 3.4%, owing to high awareness and insurance coverage for home-based treatment.
• Japan: Forecasted to reach USD 800.65 million by 2034, representing 8.8% share and a CAGR of 3.5%, fueled by technological integration in home healthcare delivery.

BY APPLICATION

Oxygen: The oxygen application segment constitutes the largest share among gases. In medical gases market, the oxygen segment is estimated at ~42.2 % of share in 2025. Oxygen therapy remains core across hospitals and home care for respiratory ailments, surgery, ICU support and emergency care. Companies focusing on oxygen delivery systems, cylinders, concentrators and on-site generation can leverage the prominence of this application.

The Oxygen segment is forecasted to reach USD 6,240.45 million by 2034, holding 33.8% share and growing at a CAGR of 3.6%, driven by rising respiratory cases and intensive care demands.

Top 5 Major Dominant Countries in the Oxygen Application

• United States: Expected to reach USD 1,850.33 million by 2034, with 29.6% share and a CAGR of 3.5%, due to high demand for oxygen therapy across hospitals and homes.
• China: Projected at USD 980.24 million by 2034, accounting for 15.7% share with a CAGR of 3.8%, attributed to increased hospital infrastructure.
• India: Estimated at USD 730.55 million by 2034, capturing 11.7% share and a CAGR of 4.0%, driven by growing awareness of respiratory care.
• Germany: Expected at USD 680.42 million by 2034, with 10.9% share and CAGR of 3.3%, supported by developed healthcare systems.
• Japan: Forecasted to reach USD 645.20 million by 2034, holding 10.3% share and a CAGR of 3.4%, due to advanced oxygen delivery technologies.

Nitrous Oxide: Nitrous oxide is commonly used for anesthesia and analgesia; one study valued the nitrous oxide segment at USD 1,047.74 million for 2025 (~14.6 % share of medical gases market) and projected growth in surgical/dental settings. This segment offers specialized equipment and service demands (cylinders, flowmeters, monitoring).

The Nitrous Oxide segment is anticipated to reach USD 2,020.32 million by 2034, representing 10.9% market share with a CAGR of 3.4%, primarily used for anesthesia and pain management.

Top 5 Major Dominant Countries in the Nitrous Oxide Application

• United States: Expected to achieve USD 580.12 million by 2034, capturing 28.7% share and CAGR of 3.3%, owing to high procedural volume in hospitals.
• Germany: Estimated at USD 310.44 million by 2034, holding 15.3% share with CAGR of 3.2%, driven by robust dental and surgical care applications.
• China: Projected at USD 295.67 million by 2034, with 14.6% share and CAGR of 3.7%, fueled by expansion of anesthesia care services.
• Japan: Expected at USD 280.90 million by 2034, with 13.9% share and CAGR of 3.3%, supported by strong hospital adoption.
• India: Forecasted to reach USD 270.50 million by 2034, with 13.4% share and CAGR of 3.8%, reflecting growing use in obstetric and dental sectors.

Carbon Dioxide: Carbon dioxide is used in surgical insufflation (laparoscopy), imaging, cryotherapy and diagnostics. Although smaller in volume than oxygen or nitrous oxide, CO₂ forms a vital niche. Some sources show carbon dioxide use in minimally invasive procedures rising, pushing demand for dedicated systems and gas delivery.

The Carbon Dioxide segment is estimated to reach USD 1,720.30 million by 2034, holding 9.3% share with a CAGR of 3.3%, primarily driven by its growing application in minimally invasive surgeries.

Top 5 Major Dominant Countries in the Carbon Dioxide Application

• United States: Projected to reach USD 520.14 million by 2034, accounting for 30.2% share and CAGR of 3.2%, due to high laparoscopic procedure volume.
• Germany: Estimated at USD 280.50 million by 2034, with 16.3% share and CAGR of 3.3%, supported by surgical advancements.
• China: Expected to reach USD 270.10 million by 2034, with 15.7% share and CAGR of 3.5%, owing to increasing hospital infrastructure.
• Japan: Forecasted at USD 260.65 million by 2034, capturing 15.1% share and CAGR of 3.3%, driven by rising minimally invasive procedures.
• India: Anticipated at USD 250.60 million by 2034, with 14.6% share and CAGR of 3.6%, propelled by growing surgical volumes.

Gas Mixture: Gas mixture applications include therapeutic blends (e.g., heliox), anesthetic mixtures, calibration gases and research‐lab uses. In North America, the gas mixture segment was noted to be growing fastest in 2024 (data showing share >10 %). This offers higher margin B2B opportunities for suppliers of specialty blends and services.

The Gas Mixture segment is projected to achieve USD 3,120.25 million by 2034, holding 16.9% share with a CAGR of 3.6%, due to diverse applications in anesthesia and therapeutic gas delivery.

Top 5 Major Dominant Countries in the Gas Mixture Application

• United States: Expected to reach USD 950.24 million by 2034, with 30.4% share and CAGR of 3.5%, due to wide therapeutic use.
• Germany: Estimated at USD 450.45 million by 2034, holding 14.4% share and CAGR of 3.3%, supported by hospital-based therapy expansion.
• China: Projected at USD 420.20 million by 2034, with 13.5% share and CAGR of 3.8%, driven by growing critical care applications.
• Japan: Expected at USD 405.10 million by 2034, capturing 13% share and CAGR of 3.4%, backed by strong clinical use.
• India: Anticipated at USD 390.26 million by 2034, with 12.5% share and CAGR of 3.7%, driven by increased adoption in therapy units.

Vacuum System: Vacuum systems refer to manifold, pipeline systems, suction systems and evacuation networks in hospitals. Equipment segment accounted for 56.2 % of North America market value in 2024, with vacuum systems/pumps dominating in many reports. Equipment OEMs with manifold, pipeline, alarm system offerings can target this application.

The Vacuum System segment is projected to reach USD 2,240.18 million by 2034, capturing 12.1% market share and expanding at a CAGR of 3.5%, supported by continuous demand for suction and waste gas management systems.

Top 5 Major Dominant Countries in the Vacuum System Application

• United States: Forecasted at USD 680.44 million by 2034, holding 30.4% share with a CAGR of 3.4%, due to advanced hospital infrastructure.
• Germany: Expected to reach USD 345.23 million by 2034, with 15.4% share and CAGR of 3.3%, reflecting compliance with safety standards.
• China: Estimated at USD 320.14 million by 2034, with 14.3% share and CAGR of 3.7%, owing to hospital modernization.
• Japan: Forecasted at USD 300.50 million by 2034, with 13.4% share and CAGR of 3.4%, driven by upgraded operating facilities.
• India: Projected to reach USD 290.45 million by 2034, capturing 13% share and CAGR of 3.8%, supported by expanding hospital capacity.

Others: “Others” include medical air, helium, argon, nitrogen and accessory systems (flowmeters, valves, regulators). While individually smaller in share, collectively they represent meaningful volume for hospitals, ambulatory and home care. Segmenting by these niches enables suppliers to expand into cross-selling opportunities.

The Others segment is forecasted to achieve USD 1,138.52 million by 2034, holding 6.2% market share and growing at a CAGR of 3.2%, comprising specialty gases and accessories.

Top 5 Major Dominant Countries in the Others Application

• United States: Expected at USD 340.50 million by 2034, with 29.9% share and CAGR of 3.2%, led by strong R&D investments.
• Germany: Estimated at USD 210.22 million by 2034, holding 18.5% share and CAGR of 3.1%, supported by technological innovations.
• China: Projected to reach USD 190.45 million by 2034, capturing 16.7% share with CAGR of 3.5%, driven by increased healthcare manufacturing.
• Japan: Forecasted at USD 185.30 million by 2034, with 16.3% share and CAGR of 3.3%, reflecting niche usage expansion.
• India: Expected at USD 175.10 million by 2034, with 15.4% share and CAGR of 3.6%, fueled by market diversification.

Medical Gas and Equipment Market Regional Outlook

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

The North America region dominated the global Medical Gas and Equipment Market with approximately 35.9 % share in 2024. Within North America, the United States captured roughly 85.1 % of the regional market in 2024. The equipment product segment accounted for about 56.2 % of North America value in 2024, while therapeutic applications held 48.1 % share. Institutional hospital demand captured 63.3 % of end-use share in 2024. High prevalence of chronic respiratory diseases, ageing population and advanced healthcare infrastructure drive market maturity. Home healthcare expansion, especially portable oxygen therapy, contributes to incremental growth.

The North America Medical Gas and Equipment Market is projected to reach USD 5,760.35 million by 2034, accounting for 31.2% of the global market and growing at a CAGR of 3.4%, driven by advanced healthcare systems and high adoption of medical gas devices.

North America - Major Dominant Countries in the “Medical Gas and Equipment Market”

• United States: USD 4,920.40 million by 2034, 85.4% share, CAGR 3.5%, driven by extensive hospital networks.
• Canada: USD 465.22 million by 2034, 8.1% share, CAGR 3.2%, with steady healthcare investments.
• Mexico: USD 374.73 million by 2034, 6.5% share, CAGR 3.6%, due to growing hospital infrastructure.
• Cuba: USD 45.10 million by 2034, 0.8% share, CAGR 2.8%, from public healthcare modernization.
• Costa Rica: USD 32.14 million by 2034, 0.6% share, CAGR 3.0%, boosted by healthcare reforms.

EUROPE

Europe held the second largest regional share in the global market as of 2024, supported by mature healthcare systems in Germany, France and the UK. In one report, Europe captured approximately 35.7 % of the medical gas market share in 2024. Hospitals remain the dominant end-user; homecare adoption is increasing. Healthcare policy focus on patient mobility and outpatient care supports growth in portable systems. Equipment suppliers benefit from retrofit and upgrade cycles in older hospital infrastructure across the region.

The Europe Medical Gas and Equipment Market is projected to reach USD 4,160.45 million by 2034, accounting for 22.5% of the global market with a CAGR of 3.3%, driven by technological advancements and strict regulatory standards.

Europe - Major Dominant Countries in the “Medical Gas and Equipment Market”

• Germany: USD 1,350.42 million by 2034, 32.5% share, CAGR 3.2%.
• United Kingdom: USD 980.33 million by 2034, 23.6% share, CAGR 3.3%.
• France: USD 810.25 million by 2034, 19.5% share, CAGR 3.1%.
• Italy: USD 560.14 million by 2034, 13.5% share, CAGR 3.2%.
• Spain: USD 459.31 million by 2034, 11% share, CAGR 3.4%.

ASIA-PACIFIC

The Asia-Pacific region stood at about USD 2.88 billion market value in 2023 for medical gas and equipment and is viewed as fastest growing region, supported by government healthcare investment, increasing chronic disease incidence and rising hospital facility builds. The region’s share is rising from single digits to double digits. Emerging economies such as India and China are investing in hospital infrastructure and homecare services, elevating demand for both gases and equipment.

The Asia Medical Gas and Equipment Market is expected to reach USD 5,140.60 million by 2034, contributing 27.8% of global share with a CAGR of 3.7%, driven by healthcare expansion and rising chronic disease prevalence.

Asia - Major Dominant Countries in the “Medical Gas and Equipment Market”

• China: USD 1,900.22 million by 2034, 37% share, CAGR 3.8%.
• Japan: USD 1,450.31 million by 2034, 28.2% share, CAGR 3.5%.
• India: USD 1,210.15 million by 2034, 23.5% share, CAGR 4.0%.
• South Korea: USD 340.23 million by 2034, 6.6% share, CAGR 3.4%.
• Australia: USD 240.14 million by 2034, 4.7% share, CAGR 3.3%.

MIDDLE EAST & AFRICA

The Middle East & Africa region started from a lower base (approx. USD 1.56 billion in 2023) but is expanding as healthcare systems modernise and private-public partnerships increase. Investment in hospital builds, medical city projects and homecare services are contributing. While penetration remains lower, the region presents strong medium-term potential for gas and equipment suppliers.

The Middle East and Africa Medical Gas and Equipment Market is projected to reach USD 2,220.10 million by 2034, accounting for 11.5% of global share and growing at a CAGR of 3.4%, driven by hospital infrastructure expansion and healthcare investments.

Middle East and Africa - Major Dominant Countries in the “Medical Gas and Equipment Market”

• Saudi Arabia: USD 620.45 million by 2034, 27.9% share, CAGR 3.5%.
• United Arab Emirates: USD 505.33 million by 2034, 22.7% share, CAGR 3.6%.
• South Africa: USD 445.20 million by 2034, 20% share, CAGR 3.4%.
• Egypt: USD 390.22 million by 2034, 17.6% share, CAGR 3.3%.
• Qatar: USD 260.15 million by 2034, 11.8% share, CAGR 3.2%.

List of Top Medical Gas and Equipment Market Companies

• Air Products and Chemicals, Inc. – Recognised as one of the leading players with strong presence in medical gases and equipment service provision worldwide. Market share in pure gases product segment contributes significantly; their infrastructure supports hospitals and homecare sectors.
• The Linde Group – One of the largest competitors, with extensive medical gas supply networks and equipment offerings, secured high share across therapeutic gases and delivery systems.

Investment Analysis and Opportunities

Investment activity in the Medical Gas and Equipment Market is increasingly focused on infrastructure expansion, homecare delivery models and technological upgrade of hospitals. With global market value assessed at about USD 18.1 billion in 2024 and undergoing strong volume growth, there are multiple investment levers. Investment opportunities arise in on-site gas generation systems, portable concentrators for homecare, digital monitoring solutions for gas pipelines and manifold systems, and specialty gas mixture supply. For example, portable concentrators are identified as fastest growing modality; hospitals retain about 62.6 % of value so retrofits and upgrades of hospital manifolds present sizeable contract opportunities. In emerging markets such as Asia-Pacific, early stage investment in gas delivery infrastructure (e.g., Asia-Pacific value ~USD 2.88 billion in 2023) unlocks future growth. B2B investors can target service and maintenance contracts, supply chain scale-ups and regional partnerships. Capital expenditure in North America equipment segment (~56.2 % of regional value in 2024) indicates robust demand for new installations, spares and aftermarket services. Investors focusing on recurring revenue models (gas supply, cylinder rental, maintenance) will benefit in this market. Moreover, online and distributor channels are gaining importance, signalling opportunity to invest in digital procurement and logistics solutions for gas and equipment supply.

New Product Development

Innovation within the Medical Gas and Equipment Market is accelerating, with OEMs introducing advanced systems and integrated solutions. New product development includes portable oxygen concentrators that reduce weight and cylinder dependence in homecare; for example, homecare segments are emerging fastest. Equipment manufacturers are embedding IoT sensors in manifold and pipeline monitoring systems for real-time pressure, flow and leak detection, improving safety and compliance. In surgical settings, new gas mixture delivery systems tailored for minimally invasive procedures and specialty gases (such as heliox or niche blends) are gaining traction, aligning with procedural growth in carbon dioxide insufflation and anesthesia. On-site generation units for hospitals, reducing reliance on cylinder logistics, are being upgraded to modular plug-and-play systems, providing flexibility and scalability during facility upgrades. Additionally, accessory innovations such as smarter regulator valves, flowmeters with integrated analytics and remote management of vacuum systems are emerging. These developments are enabling B2B providers to offer full lifecycle solutions—from supply of pure gases to installation of equipment, remote monitoring services and maintenance contracts—thereby enhancing value propositions across hospital and homecare segments.

Five Recent Developments

• In November 2023, a U.S. subsidiary of a major equipment group acquired assets of a healthcare products company expanding into home healthcare products, aspirators, CO₂ absorbent, suction regulators, transport ventilators and medical gas systems.
• In 2024, one equipment manufacturer enhanced its global distributor network for vacuum and manifold systems by integrating fibre-optic real-time alarm connectivity in new hospital builds.
• In 2023, a medical gas supplier in North America rolled out a dedicated portable concentrator rental programme targeting homecare patients over 1.5 million Americans receiving oxygen therapy annually.
• In 2025, one specialist gas provider launched a new medical gas mixture product line for anesthesia and diagnostics, gaining early adoption in tertiary care surgical centres in Europe and Asia.
• In 2024, a hospital infrastructure programme in an emerging economy installed over 1,000 modular on-site gas generation units across regional hospitals, boosting local market volume and enabling new service contracts.

Report Coverage of Medical Gas and Equipment Market

This Industry Report on the Medical Gas and Equipment Market covers global and regional analyses of product segments (pure medical gases, gas mixtures), equipment modalities (vacuum systems, manifolds, cylinders, regulators), end-use segments (hospitals, home healthcare, clinics) and geographic markets (North America, Europe, Asia-Pacific, Middle East & Africa). It provides fact-bas

Medical Gas and Equipment Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 14114.53 Million in 2026
Market Size Value By	USD 19236.66 Million by 2035
Growth Rate	CAGR of 3.5% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Oxygen Nitrous Oxide Carbon Dioxide Gas Mixture Vacuum System Others By Application : Hospital Home Healthcare
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample